Lifevantage Corporation - Common Stock (LFVN)
11.44
+0.00 (0.00%)
NASDAQ · Last Trade: Sep 9th, 5:54 AM EDT
Detailed Quote
Previous Close | 11.44 |
---|---|
Open | - |
Bid | 10.30 |
Ask | 12.99 |
Day's Range | N/A - N/A |
52 Week Range | 8.170 - 27.38 |
Volume | 0 |
Market Cap | 156.13M |
PE Ratio (TTM) | 15.46 |
EPS (TTM) | 0.7 |
Dividend & Yield | 0.1800 (1.57%) |
1 Month Average Volume | 139,716 |
Chart
About Lifevantage Corporation - Common Stock (LFVN)
Lifevantage Corp is a biotechnology company that focuses on developing and marketing products designed to promote health and wellness through the activation of the body's natural processes. The company is known for its innovative nutritional supplements and skincare products that leverage the science of cellular health and longevity. By utilizing advanced research and development, Lifevantage aims to empower consumers to enhance their overall well-being and optimize their life's potential through targeted solutions. Read More
News & Press Releases
Via Benzinga · September 5, 2025
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · September 5, 2025
Via Benzinga · September 5, 2025
LifeVantage (LFVN) reported mixed Q4 FY2025 results, beating EPS estimates at $0.17 but missing revenue forecasts. The stock fell sharply in after-hours trading.
Via Chartmill · September 4, 2025
Via Benzinga · April 10, 2025
When backtesting a portfolio strategy, you have to decide how far back to look. Should you use all available data, stretching back decades? Or should you just look at the last few years? There are arguments to be made for both options.
Via Talk Markets · February 15, 2025

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.
Via MarketBeat · February 12, 2025

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via Chartmill · February 6, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025
Steve Fife, CEO of LifeVantage Corporation (NASDAQ: LFVN), to Present at NobleCon20
In an industry where health and wellness are paramount, LifeVantage (NASDAQ: LFVN) is at the forefront of developing advanced cellular nutrition and supplementation products. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.
Via Investor Brand Network · November 12, 2024

NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November 13-14, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESSWIRE · November 12, 2024

Via Benzinga · October 25, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 3, 2024

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Today the MicroCap Rodeo - Spring into Summer will take place in-person on Thursday, June 6th, 2024 and host the executive management teams of 25 microcap companies.
Via ACCESSWIRE · June 6, 2024

LFVN stock results show that Lifevantage beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.
Via InvestorPlace · May 2, 2024